1
Enquiry period
with 29.11.2022 13:23
to 08.12.2022 14:00
2
Bidding period
with 08.12.2022 14:00
to 15.12.2022 11:00
3
Auction
with 16.12.2022 13:51
to 16.12.2022 14:01
4
Evaluation
5
Bids have been evaluated
Status Active
Estimated value without VAT 106 170,39 MDL
Period of clarifications: 29 Nov 2022, 13:23 - 8 Dec 2022, 14:00
Submission of proposals: 8 Dec 2022, 14:00 - 15 Dec 2022, 11:00
Auction start date: 16 Dec 2022, 13:51

Supplier technical support:

(+373) 79999801

Valganciclovirum 450 mg
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Full name
Constantin Nedelea
Contact phone
+37322222490
Purchase data
Date created
Date modified
29 Nov 2022, 17:09
Estimated value (without VAT)
106 170,39 MDL
The minimum downward of the price
1 060 MDL
Achizitii.md ID
21068450
Type of procedure
Open tender
Award criteria
The lowest price
Delivery address
MD-2009, MOLDOVA, mun.Chişinău, mun.Chişinău, conform listei de distributie
Contract period
1 Jan 2023 02:00 - 31 Dec 2023 02:00
List of positions
1)
Title
Valganciclovirum 450 mg CPV: 33600000-6 - Pharmaceutical products
Quantity: 400.0
Unit of measurement: Bucata
Documents of the procurement procedure
Propunerea financiară_29.11.2022
Bidding Documents
Propunerea financiară_29.11.2022
29.11.22 13:23
Anunt de participare_29.11.2022.signed
Bidding Documents
Anunt de participare_29.11.2022
29.11.22 13:23
Date bancare
Bidding Documents
Date bancare
29.11.22 13:23
Propunerea tehnică_29.11.2022
Bidding Documents
Propunerea tehnică_29.11.2022
29.11.22 13:23
Model contract_med onco 2023_repetat 2
Bidding Documents
Model contract_med onco 2023_repetat 2
29.11.22 13:23
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
29.11.22 13:23
Cerere de participare_Model
Bidding Documents
Cerere de participare_Model
29.11.22 13:23
DUAE Model
Bidding Documents
DUAE Model
29.11.22 13:23
Documentatia standard_29.11.2022.signed
Bidding Documents
Documentatia standard_29.11.2022
29.11.22 13:23
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
29.11.22 13:23
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
29.11.22 13:23
Lista de distribuţie_Med onco si imunosupresive 2023_repetat nr. 2
Bidding Documents
Lista de distribuţie_Med onco si imunosupresive 2023_repetat nr. 2
29.11.22 13:23
Propunerea tehnică_30.11.2022
Bidding Documents
Propunerea tehnică_30.11.2022
29.11.22 17:09
Lista de distribuţie_30.11.2022
Bidding Documents
Lista de distribuţie_30.11.2022
29.11.22 17:09
Anunt de participare_30.11.2022
Bidding Documents
Anunt de participare_30.11.2022
29.11.22 17:09
Propunerea financiară_30.11.2022
Bidding Documents
Propunerea financiară_30.11.2022
29.11.22 17:09

The offers of the participants are available below, you can view the documents for the offers by clicking on the folder icon.

Based on the Working Group Decision, the selection of a winner requires:

1) Choose winner by clicking the button.

2) Отправить в течении 3 дней на почту AAP bap@tender.gov.md отсканированное решение рабочей группы.

4) After choosing the winner, press the button: "Confirm"..

Qualification
Participant(s) name(s)
Normalized price
Status
1
Participant(s) name(s):

DITA ESTFARM S.R.L

Normalized price: 101 851,68 MDL
Status: In consideration
Reason: Not indicated
Qualification documents
Documents folder missing
Documents provided with the proposal
2
Participant(s) name(s):

Lismedfarm

Normalized price: 137 520 MDL
Status: Awaiting

Documents such as "Qualification Documentation", "financial proposal" and "Illustration" will be browseable for all only after your offer has been placed in "pending" status.

Reason: Not indicated
Qualification documents
Documents folder missing
Documents provided with the proposal
The history of the auction
View auction
Litigation
File an appeal
Unfortunately, questions can be asked only during the "Active" period.
Clarifications